-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Inflammatory bowel disease (IBD) is an immuno-mediated gastrointestinal (GI) inflammatory condition of chronic tissue damage, including ulcerative colitis (UC) and Crohn's disease (CD).
Because other immune diseases such as rheumatoid arthritis (RA), psoriasis, and systemic lupus erythematosus are positively associated with cardiovascular events, the researchers suspect that IBD's autoimmune properties are also associated with the risk of cardiovascular (CV) events.
addition, a national queue study in Denmark looked at 86,790 patients with primary heart attack (MI), 1,030 of whom had IBD (75.9% UC and 24.1% CD), and found that IBD seizures at MI were associated with an increased risk of recurrence within MI30.
study aims to investigate the clinical outcome of myocardial infarction (MI) in IBD patients.
researchers used sample data from 1998 to 2010 from inpatients across the United States to conduct cross-sectional studies.
clinical outcomes with or without IBD diagnosis with all eligible MI patients.
analysis of the data, the correlation analysis of the mixed factors was corrected, and the effects of UC and CD on mi-mortality in the hospital were determined by the regression of multi-factor logic.
study included 2629,161 MI patients, including 3,607 UC and 3,784 CD patients.
UC (OR, 1.12; 95% CI 0.98-1.29) and CD (OR 0.99; 95% CI 0.86-1.15) did not affect in-hospital mortality in MI patients.
mortality rate (7.75 per cent vs. 7.05 per cent) for MI patients who did or did not combine UC; There was no difference in in-hospital mortality rates (6.50% vs.6.59%) between patients with p-0.25) or MI patients with combined or non-combined CDs; p = 0.87）。
IBD patients have longer hospital stays (LOS) than non-IBD patients, and the total cost of care for UC patients is higher ($65182 vs. $53542; p .lt;001).
this study, retrospective analysis showed that IBD did not affect in-hospital mortality from myocardial infarction.
, patients with MI with IBD have longer LOS.
total hospitalization costs for UC patients were higher than for MI patients without IBD.
